Jennifer L Taubert Insider Trading $JNJ JOHNSON & JOHNSON
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer L Taubert.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer L Taubert. Jennifer L Taubert is EVP, WW Chair, Pharmaceuticals in JOHNSON & JOHNSON ($JNJ).
Jennifer L Taubert in JOHNSON & JOHNSON
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer L Taubert: EVP, WW Chair, Pharmaceuticals
Holdings: 119,014 shares
Current Value: $13,505,709
Latest Transaction: Feb 17 2021
$JNJ Market Capitalization: $308.51B
$JNJ Previous Close: $113.48
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jennifer L Taubert in JOHNSON & JOHNSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 2,177 | 0 | 0 | |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 11,429 | 0 | 0 | |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 165.55 | 5,268 | 872,117 | 115,126 | 120.4 K to 115.1 K (-4.38 %) |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 165.55 | 797 | 131,943 | 120,394 | 121.2 K to 120.4 K (-0.66 %) |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 2,177 | 0 | 121,191 | 119 K to 121.2 K (+1.83 %) |
| Feb 17 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 11,429 | 0 | 119,014 | 107.6 K to 119 K (+10.62 %) |
| Feb 10 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 0.00 | 3,739 | 0 | 3,739 | |
| Feb 10 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 0.00 | 11,429 | 0 | 11,429 | |
| Feb 10 2021 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 164.62 | 82,127 | 13,519,747 | 82,127 | |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 8,360 | 0 | 0 | |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 150.46 | 4,277 | 643,517 | 107,585 | 111.9 K to 107.6 K (-3.82 %) |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 150.46 | 3,951 | 594,467 | 111,862 | 115.8 K to 111.9 K (-3.41 %) |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 7,724 | 0 | 115,813 | 108.1 K to 115.8 K (+7.15 %) |
| Feb 18 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 8,360 | 0 | 108,089 | 99.7 K to 108.1 K (+8.38 %) |
| Feb 12 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 0.00 | 3,570 | 0 | 3,570 | |
| Feb 12 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 0.00 | 8,360 | 0 | 8,360 | |
| Feb 12 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 151.41 | 91,324 | 13,827,367 | 91,324 | |
| Feb 04 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 48,312 | 0 | 0 | |
| Feb 04 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 149.32 | 23,721 | 3,542,020 | 99,729 | 123.5 K to 99.7 K (-19.22 %) |
| Feb 04 2020 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 48,312 | 0 | 123,450 | 75.1 K to 123.5 K (+64.30 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 0.00 | 3,297 | 0 | 3,297 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 9,748 | 0 | 0 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | A | 131.94 | 67,397 | 8,892,360 | 67,397 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Option Exercise | M | 0.00 | 8,529 | 0 | 0 | |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 131.94 | 6,236 | 822,778 | 73,751 | 80 K to 73.8 K (-7.80 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Grant | A | 0.00 | 1,599 | 0 | 79,987 | 78.4 K to 80 K (+2.04 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 9,748 | 0 | 78,388 | 68.6 K to 78.4 K (+14.20 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Payment of Exercise | F | 132.00 | 3,565 | 470,580 | 68,640 | 72.2 K to 68.6 K (-4.94 %) |
| Feb 12 2019 | JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Phar ... | Buy | M | 0.00 | 8,529 | 0 | 72,205 | 63.7 K to 72.2 K (+13.39 %) |
Page: 1